Abstract
The recent paper by Dudley et al. (1) entitled “Detection and surveillance of bladder cancer using urine tumor DNA” adds to the burgeoning evidence that massively-parallel sequencing of urinary DNA reliably detects tumour-associated mutations in urinary DNA. This approach promises to resolve the long overdue need for a sensitive and specific non-invasive test for bladder cancer. In this editorial we discuss the existing body of evidence and what the study by Dudley et al. contributes to this rapidly-evolving field of cancer research.
| Original language | English |
|---|---|
| Pages (from-to) | S204-S207 |
| Number of pages | 4 |
| Journal | Translational Cancer Research |
| Volume | 8 |
| Issue number | Suppl 2 |
| Early online date | 4 Mar 2019 |
| DOIs | |
| Publication status | Published - 31 Mar 2019 |
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Access to Document
- Douglas_Ward_&_Richard_Bryan_Massively_parallel_sequencing_of_urinary_DNA_Translational_Cancer_Research_2019
Checked for eligibility: 19/03/2019 This article was published in Translational Cancer Research, 2019. The final published version can be found at: http://dx.doi.org/10.21037/tcr.2019.03.03